Presented at the III International Symposium on Mushroom Nutrition in Milan on Saturday, March 10th, 2001.
This case study outlines the changes in CD4 levels and viral loads of eight (8) HIV+ patients on Coriolus versicolor supplementation levels of 1.5 grams per day over a twelve (12) month period. Results: Coriolus versicolor supplementation as low as 1.5 grams per day can increase CD4 levels and decrease viral loads in HIV+ patients. For similar impact in post-HAART patients the supplementation levels must be at 3.0 grams per day.
To contact Ms. Marijke Pfeiffer
Centrum Voor Integrale GeneeskundesAmsterdam, The Netherlands
Fax:31-20-624-9710
Email: cig@xs4all.nl
Clinical Articles
The following section outlines the clinical papers, posters and proposals that refer to the clinical use of MRL mushroom nutrition products. This information is for healthcare practitioners only and should not be provided to members of the general public.
Download PDF
Clinical articles
-
Hericium Erinaceus Prevents DEHP-Induced Mitochondrial Dysfunction and Apoptosis in PC12 Cells
Ines Amara (1)(2), Maria Scuto (2), Agata Zappalà (2), Maria Laura Ontario (2), Antonio Petralia (3), Alwa Abid -Essefi (1), Luigi Maiolino (3), Anna Signorile (4), Angela Trovato Salinaro (2) and Vittorio Calabrese (2). -
Effect of combined therapy polyhexamethylene biguanide and Coriolus-MRL on human papilloma virus (HPV) cervical and vulvar-related lesions
D. Gincheva(1), V. Gincheva(2), E. Konova(1)
-
Nutritional Mushroom Treatment in Meniere’s Disease with Coriolus versicolor: A Rationale for Therapeutic Intervention in Neuroinflammation and Antineurodegeneration
Maria Scuto (1),y , Paola Di Mauro (2),y, Maria Laura Ontario (1), Chiara Amato (2), Sergio Moda_eri (1), Domenico Ciavardelli (3,4), Angela Trovato Salinaro (1), Luigi Maiolino (2),* and Vittorio Calabrese (2) -
Evaluation of the prebiotic potential of Coriolus versicolor-Effect on the human gut microbiota.
C.M. Costa, S. Silva, L. Pimentel and M.M. Pintado